Diamyd Medical AB (publ) (STO:DMYD.B)

Revenue by Segment

Financials in millions SEK. Fiscal year is September - August.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Aug 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2018	Aug 31, 2017
Pharmaceuticals	477.00K	130.00K	130.00K	546.00K	2.59M
Total	477.00K	130.00K	130.00K	546.00K	2.59M

Data Source: S&P Global Market Intelligence Last updated: Oct 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 13, 2026

Data Sources Report a data error